Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733650 | Critical Reviews in Oncology/Hematology | 2018 | 6 Pages |
Abstract
The quality of reporting in phase II trials in oncology is a field that has been investigated very little (13 publications). When it is studied, the estimated level of quality is not satisfactory, whatever the method employed. The use of an overall score of evaluation is a path which should be pursued, in order to get reliable results. It also seems necessary to propose strong recommendations, which would create a consensus for the methodology and the reporting of these studies.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Romain Rivoirard, Julien Langrand-Escure, Mathieu Oriol, Fabien Tinquaut, Franck Chauvin, Chloé Rancoule, Nicolas Magné, Aurélie Bourmaud,